Page last updated: 2024-10-24

cefuroxime and Cholecystitis, Acute

cefuroxime has been researched along with Cholecystitis, Acute in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Cholecystitis, Acute: Acute inflammation of the GALLBLADDER wall. It is characterized by the presence of ABDOMINAL PAIN; FEVER; and LEUKOCYTOSIS. Gallstone obstruction of the CYSTIC DUCT is present in approximately 90% of the cases.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Loozen, CS1
Kortram, K1
Kornmann, VN1
van Ramshorst, B1
Vlaminckx, B1
Knibbe, CA1
Kelder, JC1
Donkervoort, SC1
Nieuwenhuijzen, GA1
Ponten, JE1
van Geloven, AA1
van Duijvendijk, P1
Bos, WJ1
Besselink, MG1
Gouma, DJ1
van Santvoort, HC1
Boerma, D1

Trials

1 trial available for cefuroxime and Cholecystitis, Acute

ArticleYear
Randomized clinical trial of extended versus single-dose perioperative antibiotic prophylaxis for acute calculous cholecystitis.
    The British journal of surgery, 2017, Volume: 104, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Cefazolin; Cefuroxime

2017